Meghan Ross, Associate Editor

Forever Beautiful Bee Pollen and Forever Beautiful Infinity were found to be forever dangerous to consumers.

Sanofi and Regeneron Pharmaceutics, Inc, have convinced the FDA that their atopic dermatitis treatment works well enough to undergo accelerated development and regulatory review.

The FDA today approved hydrocodone bitartrate, an extended-release opioid analgesic for treating severe pain that requires daily long-term opioid treatment and for which other treatment options are inadequate.

On the heels of the FDA approval of paliperidone palmitate as either a monotherapy or adjunctive therapy for schizoaffective disorder, Janssen Pharmaceuticals, Inc, has submitted a new drug application for the medication's use as a 3-month atypical antipsychotic treatment for schizophrenia in adults.

After the Drug Enforcement Administration revoked the Tampa-based pharmacy's registration to sell controlled substances and seized its drugs, the company fought back with a lawsuit.

A new liquid drug formulation from Teva Pharmaceutical Industries Ltd. will allow some cancer patients to see their therapy administered faster.

The Congolese strain apparently similar to the virus that affected DRC and Gabon in the mid-1990s.

Some pharmacists feel tired after being on their feet all day and never getting a chance to sit down. To ease the annoyance of standing all day, one pharmacist in Broken Arrow, Oklahoma, allegedly took matters into his own hands.

The first and only FDA-approved vaccine for active immunization to prevent invasive serogroup B meningococcal disease in patients aged 10 to 25 years is now available for order by retail pharmacies.

A Genzyme and Isis Pharmaceuticals Inc. study suggests that mipomersen sodium injections reduce the odds of major adverse cardiovascular events in patients with familial hypercholesterolemia, compared with the 2 years prior to therapy.

A long-term study of Celgene Corporation's apremilast showed that the oral selective inhibitor of phosphodiesterase 4 provides relief to adult patients with active psoriatic arthritis, as well as adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

A sports supplement company is voluntarily recalling its Mayhem dietary supplement capsules marketed to bodybuilders, after the FDA found 2 undeclared drugs in the product.

Patients with type 2 diabetes mellitus may see a reduction in blood sugar levels and body weight with empagliflozin treatment, according to data from Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals Inc.

A Merck study found patients who received a cholesterol-lowering combination of ezetimibe/simvastatin experienced fewer major cardiovascular events than those taking simvastatin alone.

While some pharmacies have their drugs stolen by robbers, a pharmacy in Tampa, Florida, had its drugs taken by the Drug Enforcement Administration.

The current Ebola epidemic in the Democratic Republic of the Congo stems from a different strain of the virus than the outbreak wreaking havoc on West Africa, according to data from a French research organization.

Solgar Inc. is voluntarily recalling its ABC Dophilus Powder, after the US Centers for Disease Control found a potentially dangerous fungus present in the product, according to the FDA.

Doctor was serving as the chief medical officer in Sierra Leone when he became infected with the disease.

Walgreens will appeal a $1.4 million verdict after 1 of its pharmacists in Indiana violated the Health Insurance Portability and Accountability Act when she reviewed prescription records of a woman who once dated her husband.

The FDA is taking a look at a trial that showed 30 months of dual antiplatelet blood-thinning therapy decreased the risk of heart attack and clot formation in stents, yet increased the overall risk of death compared with 12 months of the treatment.

A Nebraska hospital has reported that one of its patients, a surgeon who had been working in Sierra Leone, has died from Ebola.

A pharmacist in the United Kingdom who got a little too curious about his friends' and family's medical records has been convicted of data protection offenses and fined.

One pharmacist in England had more than a trick up his sleeve.

Actavis's supplemental New Drug Application for asenapine to treat manic or mixed episodes related to bipolar disorder in pediatric patients has been accepted by the FDA and given priority review status.

Test results for group A streptococcus infection are about to appear much faster.

An Irish woman has settled a damages claim of approximately $47,000 against a pharmacy she said showed her husband closed-circuit TV footage of her purchasing a pregnancy test kit, according to The Irish Times.

A study from Merck has demonstrated high response to grazoprevir/elbasvir with and without ribavirin across various hepatitis C virus populations, including difficult-to-cure patients.

The FDA has approved Allergan Inc.'s request to market 2 new styles of its silicone breast implants for use in breast reconstruction, augmentation, and revision surgery.

There's some good news for the 750,000 Americans with schizoaffective disorder, as the FDA has approved paliperidone palmitate as either monotherapy or adjunctive therapy to treat the disease, according to drugmaker Janssen Pharmaceuticals, Inc.

A trio of studies from AbbVie provides good news for patients with hepatitis C virus, including those with comorbid HIV or cirrhosis.